Immunology follow-up after rituximab treatment in pediatric non Hodgkin lymfoma patients

Hlaváčková,  Eva; Křenová,  Zdenka; Štěrba,  Jaroslav; Litzman,  Jiří

Immunology follow-up after rituximab treatment in pediatric non Hodgkin lymfoma patients

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Immunology follow-up after rituximab treatment
Authors	HLAVÁČKOVÁ Eva KŘENOVÁ Zdenka ŠTĚRBA Jaroslav LITZMAN Jiří
Year of publication	2018
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	Rituximab treatment leads to absolute transitional CD19+ B lymphocytopenia. IgG decrease could be delayed after the B cell recovery in the periphery. Clinical and laboratory sights of antibody secondary deficiency should be regularly monitored.
Related projects:	Poruchy tvorby protilátek a komplementového systému